Merck, a leading science and technology company, announced the launch of the ChemiSphere® app, a digital tool that allows scientists to instantly access product documentation and quality information via 2D barcodes on the Life Science products offered by Merck. The app is powered by the company’s secure digital traceability platform M-Trust™ and is designed to make data retrieval faster and more reliable, helping labs reduce manual steps and improve data integrity.

Siemens Healthineers is to co-lead a major EU research initiative dedicated to improving the diagnosis, treatment and monitoring of Alzheimer’s Disease (AD). The project, ACCESS-AD, aims to create a collaborative, patient-centered strategy for Alzheimer’s care across Europe. It begins in January 2026 and unites more than 30 European partners from hospitals, universities, patient organizations, and industry, representing expertise in neurology, imaging, data science, and patient advocacy.

A new attempt to create a national, longitudinal health record was one of the big ideas in the 10 Year Health Plan. However, the use case and architecture is far from clear, and there are some big commercial issues to address with health tech vendors...

The NHS has a troubled history when it comes to national record and data projects.

Bayer and Cradle announced that they have entered a three-year strategic collaboration to deploy Cradle’s scientific AI software platform for protein engineering. As part of the collaboration, Bayer will integrate the generative AI platform into existing R&D workflows to enhance lead generation and optimization across its therapeutic antibody pipeline.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging (EVI) of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging [3]. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide advanced solutions for the treatment of patients with coronary artery disease, the most frequent type of heart disease, affecting more than 300 million people worldwide [4].

UK trade association AXREM and health tech growth specialist Highland have extended their partnership for two further years, reaffirming a shared commitment to supporting growth across the UK’s diagnostic and health technology markets.

AXREM represents member companies that collectively provide the majority of diagnostic medical imaging and radiotherapy equipment used in UK hospitals.

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which he has worked alongside technology innovators and the hospital teams that put solutions into practice for patient care.

When Yousif saw an opportunity advertised to learn skills that would help him begin a technology career, his attention was caught.